Singapore markets close in 5 hours 5 minutes

Straits Times Index
3,165.93
-21.73(-0.68%)
Nikkei
37,073.61
-1,006.09(-2.64%)
Hang Seng
16,160.24
-225.63(-1.38%)
FTSE 100
7,877.05
+29.06(+0.37%)
Bitcoin USD
61,829.30
-141.71(-0.23%)
CMC Crypto 200
1,278.31
+392.77(+42.76%)

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

90.07

-0.40

(-0.44%)

At close: 04:00PM EDT

90.07

0.00

(0.00%)

After hours:

04:20PM EDT

Loading interactive chart…

Zacks
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
BioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GuruFocus.com
Insider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...
Biomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing and commercializing innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases, has reported an insider sell according to a recent SEC filing.